Science ❯ Biotechnology ❯ Drug Development
FDA-Approved Drugs Seizure Medications Therapeutic Proteins Gene Therapy Cancer Treatment Phase 1 Trials Innovative Therapies
The INHBE-targeting siRNA produced durable Activin E suppression supporting infrequent dosing.